Read more (Oxford University Innovation Website)
Drugs from bugs tops list of LAB282’s first round of grants
CRE
27 July 2017
LAB282, the £13m drug discovery partnership for Oxford University, has made its first wave of awards, backing projects targeting cardiovascular and infectious diseases.